Investigating the Effects of Olaparib on the Susceptibility of Glioblastoma Multiforme Tumour Cells to Natural Killer Cell-Mediated Responses

• Main Authors: Jennifer Moran (Author), Eimear Mylod (Author), Laura E. Kane (Author), Caroline Marion (Author), Emily Keenan (Author), Marianna Mekhaeil (Author), Joanne Lysaght (Author), Kumlesh K. Dev (Author), Jacintha O'Sullivan (Author), Melissa J. Conroy (Author)
• Formato: Libro
• Publicado: MDPI AG, 2023-01-01T00:00:00Z.
• Subjects: article
• Acceso en liña: Connect to this object online.

Glioblastoma multiforme (GBM) is the most common adult primary brain malignancy, with dismal survival rates of ~14.6 months. The current standard-of-care consists of surgical resection and chemoradiotherapy, however the treatment response is limited by factors such as tumour heterogeneity, treatment...